Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- for the
- Lungenfachklinik Immenhausen
- Aix-Marseille Université
- Genentech, Inc
- University of Campania Luigi Vanvitelli
- Asklepios Klinik St. Georg
- Wayne State University
- Aichi Cancer Center Hospital and Research Institute
- Maria Sklodowska-Curie Institute of Oncology
- Hospital Regional Universitario Carlos Haya
- AOU San Gerardo
- Minnesota Oncology
- Kaiser Permanente
- Pontifícia Universidade Católica do Rio Grande do Sul
- University of California at Los Angeles
- Centro Internacional de Estudios Clinicos
- IRCCS Istituto Europeo di Oncologia - Milano
- Istanbul University - Cerrahpaşa
- Seoul National University
- University of California at Davis
Research output: Contribution to journal › Article › peer-review
4320
Link opens in a new tab
Scopus
citations